| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,438 | 14,388 | 12,378 | 16,547 | | Cost of Revenue | 5,771 | 5,405 | 8,799 | 10,375 | | | Gross Profit | 10,667 | 8,983 | 3,579 | 6,172 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,502 | 2,825 | 3,255 | 3,284 | | Non Recurring |
-
|
-
|
-
| 275,684 | | Others | 5,253 | 5,191 | 5,316 | 10,376 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,912 | 967 | (4,992) | (283,172) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 921 | (8,610) |
-
|
-
| | Earnings Before Interest And Taxes | 3,833 | (7,643) | (4,992) | (283,172) | | Interest Expense | 1,658 | 1,488 | 1,544 | 1,437 | | Income Before Tax | 2,175 | (9,131) | (6,536) | (284,609) | | Income Tax Expense | (18) | 39 | 18 | (63) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,193 | (9,170) | (6,554) | (284,546) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,193 | (9,170) | (6,554) | (284,546) | | Preferred Stock And Other Adjustments | (24) | (24) | (24) | (21) | | | Net Income Applicable To Common Shares | $2,169 | ($9,194) | ($6,578) | ($284,567) |
|
0.51% Nasdaq 
Income Statement
